Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Molecules ; 27(9)2022 Apr 27.
Artigo em Inglês | MEDLINE | ID: mdl-35566133

RESUMO

Oxidative stress is a key underlying factor in cognitive decline and atherosclerosis. Oxidative stress occurs at the cellular level with an imbalance between reactive oxygen species and reactive nitrogen species and a deficiency in antioxidants. Mounting evidence suggests that berry flavonoids may promote cellular health by exerting antioxidant properties. Black currant and various berry extracts were tested in microglia (BV-2) and cardiomyocyte (HL-1) cell lines to study their biological effects. The principal ingredients in black currant and cranberry extract-delphinidin 3-rutinoside (D3R) and cyanidin 3-glucoside (C3G), were also assessed. A menadione-induced oxidative stressor was used, and its output was quantified to detect oxidative stress (CellROXTM). Black currant extract had similar antioxidant effects as N-acetylcysteine (NAC) in HL-1 cells with regard to cellular protection, whereas cranberry extract was ineffective. In contrast, cranberry extract was comparable in effectiveness to black currant extract in BV-2 cells. D3R and C3G also reduced oxidative stress similarly to whole berry extracts, which indicates that these ingredients may confer the antioxidant effects of berries. Black currant and cranberry extracts inhibit oxidative stress in microglial and cardiomyocyte cell lines. Black currant extract was more effective in reducing oxidative stress in the HL-1 cells, whereas cranberry extract was comparable in reducing oxidative stress in the BV-2 cells. The results suggest that berry flavonoids exert neuro- and cardioprotective effects.


Assuntos
Ribes , Vaccinium macrocarpon , Antocianinas/farmacologia , Antioxidantes/farmacologia , Frutas , Microglia , Miócitos Cardíacos , Estresse Oxidativo , Extratos Vegetais/farmacologia
2.
Mil Med ; 180(7): 742-7, 2015 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-26126243

RESUMO

INTRODUCTION: Mineral supplements such as calcium and iron are readily available over the counter and are some of the most frequently consumed dietary supplements. Health care providers also prescribe mineral supplements for treatment of certain conditions and to maintain health. OBJECTIVE: This study examines trends in mineral-supplement prescriptions dispensed by military treatment facilities. METHODS: We examined data from the DoD Pharmacy Data Transaction Service to determine the nature of mineral-supplement prescriptions dispensed by MTFs from 2007 through 2011. RESULTS: Overall, 1,785,158 calcium, 844,655 iron, 166,207 magnesium, and 23,297 zinc prescriptions were dispensed over this 5-year period. Although the number of zinc prescriptions decreased considerably by an average of 30% across the 5-year period, calcium and magnesium prescriptions increased by 3% and 8%, respectively. The number of iron prescriptions dispensed was relatively stable across the 5 years. CONCLUSIONS: Patterns of mineral-supplement prescriptions in the military changed over the 5-year period examined. However, the patterns within the DoD medical system may or may not represent those of the civilian medical system. Because we could not determine the reasons why the mineral supplements were prescribed, we cannot report whether the supplements were effective for the intended uses.


Assuntos
Suplementos Nutricionais/provisão & distribuição , Prescrições de Medicamentos/estatística & dados numéricos , Hospitais Militares/estatística & dados numéricos , Militares , Minerais/provisão & distribuição , Necessidades Nutricionais , Assistência Farmacêutica/tendências , Humanos
3.
Mil Med ; 179(6): 580-92, 2014 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-24902123

RESUMO

BACKGROUND: Eczema affects 3.5% of the global population, with peak prevalence during infancy. Eczema has no cure, but probiotics have been suggested as a preventative measure. OBJECTIVE: To comprehensively analyze the impact of prenatal and postnatal probiotic supplementation on the prevention of infantile and childhood eczema. METHODS: MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, and PubMed were searched for randomized controlled trials regarding probiotic usage and eczema development from 1945 to 2013. Participants included were 7 years old or younger with probiotic exposure in utero or below 6 months of age and who was not diagnosed previously. RESULTS: 27 publications describing 16 studies assessing 10 probiotics in 2,797 participants met our criterion. The pooled relative risk of all the studies, 0.74 (95% confidence interval 0.67, 0.82), indicated that probiotic supplementation in the first several years of life did have a significant impact on development of eczema. During evaluation of the studies, heterogeneity of terms and definitions for similar primary and secondary outcomes were identified. CONCLUSION: The use of probiotic supplements during pregnancy and/or during infancy creates a statistically significant decline in the incidence of eczema. The heterogeneity of terms and definitions regarding eczema is the major limitation of these studies.


Assuntos
Bifidobacterium , Suplementos Nutricionais/microbiologia , Eczema/prevenção & controle , Lactobacillus , Probióticos/uso terapêutico , Criança , Pré-Escolar , Dermatite Atópica/diagnóstico , Eczema/diagnóstico , Terapias Fetais , Humanos , Lactente , Recém-Nascido , Terminologia como Assunto
4.
Int J Radiat Oncol Biol Phys ; 86(5): 986-92, 2013 Aug 01.
Artigo em Inglês | MEDLINE | ID: mdl-23845847

RESUMO

PURPOSE: We are characterizing the Gottingen minipig as an additional large animal model for advanced drug testing for the acute radiation syndrome (ARS) to enhance the discovery and development of novel radiation countermeasures. Among the advantages provided by this model, the similarities to human hematologic parameters and dynamics of cell loss/recovery after irradiation provide a convenient means to compare the efficacy of drugs known to affect bone marrow cellularity and hematopoiesis. METHODS AND MATERIALS: Male Gottingen minipigs, 4 to 5 months old and weighing 9 to 11 kg, were used for this study. We tested the standard off-label treatment for ARS, rhG-CSF (Neupogen, 10 µg/kg/day for 17 days), at the estimated LD70/30 total-body γ-irradiation (TBI) radiation dose for the hematopoietic syndrome, starting 24 hours after irradiation. RESULTS: The results indicated that granulocyte colony stimulating factor (G-CSF) enhanced survival, stimulated recovery from neutropenia, and induced mobilization of hematopoietic progenitor cells. In addition, the administration of G-CSF resulted in maturation of monocytes/macrophages. CONCLUSIONS: These results support continuing efforts toward validation of the minipig as a large animal model for advanced testing of radiation countermeasures and characterization of the pathophysiology of ARS, and they suggest that the efficacy of G-CSF in improving survival after total body irradiation may involve mechanisms other than increasing the numbers of circulating granulocytes.


Assuntos
Síndrome Aguda da Radiação/tratamento farmacológico , Modelos Animais de Doenças , Fator Estimulador de Colônias de Granulócitos/uso terapêutico , Hematopoese/efeitos dos fármacos , Porco Miniatura , Irradiação Corporal Total/efeitos adversos , Síndrome Aguda da Radiação/sangue , Síndrome Aguda da Radiação/mortalidade , Animais , Proteína C-Reativa/análise , Avaliação Pré-Clínica de Medicamentos/métodos , Filgrastim , Hematopoese/efeitos da radiação , Mobilização de Células-Tronco Hematopoéticas/métodos , Humanos , Macrófagos/citologia , Macrófagos/efeitos dos fármacos , Masculino , Monócitos/citologia , Monócitos/efeitos dos fármacos , Neutropenia/tratamento farmacológico , Órgãos em Risco/efeitos da radiação , Proteínas Recombinantes/uso terapêutico , Reprodutibilidade dos Testes , Suínos
5.
J Clin Endocrinol Metab ; 98(5): 1982-90, 2013 May.
Artigo em Inglês | MEDLINE | ID: mdl-23539727

RESUMO

CONTEXT: Patients previously treated with desiccated thyroid extract (DTE), when being switched to levothyroxine (L-T4), occasionally did not feel as well despite adequate dosing based on serum TSH levels. OBJECTIVE: Our objective was to investigate the effectiveness of DTE compared with L-T4 in hypothyroid patients. DESIGN AND SETTING: We conducted a randomized, double-blind, crossover study at a tertiary care center. PATIENTS: Patients (n = 70, age 18-65 years) diagnosed with primary hypothyroidism on a stable dose of L-T4 for 6 months were included in the study. INTERVENTION: Patients were randomized to either DTE or L-T4 for 16 weeks and then crossed over for the same duration. OUTCOME MEASURES: Biochemical and neurocognitive tests at baseline and at the end of each treatment period were evaluated. RESULTS: There were no differences in symptoms and neurocognitive measurements between the 2 therapies. Patients lost 3 lb on DTE treatment (172.9 ± 36.4 lb vs 175.7 ± 37.7 lb, P < .001). At the end of the study, 34 patients (48.6%) preferred DTE, 13 (18.6%) preferred L-T4, and 23 (32.9%) had no preference. In the subgroup analyses, those patients who preferred DTE lost 4 lb during the DTE treatment, and their subjective symptoms were significantly better while taking DTE as measured by the general health questionnaire-12 and thyroid symptom questionnaire (P < .001 for both). Five variables were predictors of preference for DTE. CONCLUSION: DTE therapy did not result in a significant improvement in quality of life; however, DTE caused modest weight loss and nearly half (48.6%) of the study patients expressed preference for DTE over L-T4. DTE therapy may be relevant for some hypothyroid patients.


Assuntos
Suplementos Nutricionais , Terapia de Reposição Hormonal , Hipotireoidismo/dietoterapia , Receptores dos Hormônios Tireóideos/agonistas , Glândula Tireoide/química , Tiroxina/uso terapêutico , Extratos de Tecidos/uso terapêutico , Adulto , Idoso , Animais , Cognição/efeitos dos fármacos , Transtornos Cognitivos/induzido quimicamente , Transtornos Cognitivos/etiologia , Transtornos Cognitivos/prevenção & controle , Estudos Cross-Over , Suplementos Nutricionais/efeitos adversos , Método Duplo-Cego , Feminino , Terapia de Reposição Hormonal/efeitos adversos , Humanos , Hipotireoidismo/sangue , Hipotireoidismo/tratamento farmacológico , Hipotireoidismo/fisiopatologia , Masculino , Pessoa de Meia-Idade , Preferência do Paciente , Qualidade de Vida , Índice de Gravidade de Doença , Hormônios Tireóideos/sangue , Tiroxina/efeitos adversos , Extratos de Tecidos/efeitos adversos , Redução de Peso/efeitos dos fármacos , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA